Wedbush Reiterates an 'Outperform' on Biodel (BIOD); Significant 2010 Catalysts
Tweet Send to a Friend
Wedbush reiterates an Outperform rating on Biodel (Nasdaq: BIOD), price target $17.
Wedbush analyst says, "Management submitted the NDA for ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Wedbush analyst says, "Management submitted the NDA for ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE